Folgen
Mayur Sarangdhar, PhD, MRes
Mayur Sarangdhar, PhD, MRes
Bestätigte E-Mail-Adresse bei cchmc.org - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data
M Sarangdhar, S Tabar, C Schmidt, A Kushwaha, K Shah, JE Dahlquist, ...
Nature biotechnology 34 (7), 697-700, 2016
552016
Dipeptidyl peptidase‐4 inhibitors moderate the risk of genitourinary tract infections associated with sodium‐glucose co‐transporter‐2 inhibitors
GP Fadini, BM Bonora, S Mayur, M Rigato, A Avogaro
Diabetes, Obesity and Metabolism 20 (3), 740-744, 2018
502018
Pharmacovigilance assessment of the association between Fournier’s gangrene and other severe genital adverse events with SGLT-2 inhibitors
GP Fadini, M Sarangdhar, F De Ponti, A Avogaro, E Raschi
BMJ Open Diabetes Research and Care 7 (1), e000725, 2019
342019
Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System
GP Fadini, M Sarangdhar, A Avogaro
BMJ Open Diabetes Research and Care 6 (1), e000475, 2018
342018
The impact of marijuana on antidepressant treatment in adolescents: clinical and pharmacologic considerations
SE Vaughn, JR Strawn, EA Poweleit, M Sarangdhar, LB Ramsey
Journal of Personalized Medicine 11 (7), 615, 2021
242021
Pharmacovigilance evaluation of the association between DPP-4 inhibitors and heart failure: stimulated reporting and moderation by drug interactions
GP Fadini, M Sarangdhar, A Avogaro
Diabetes Therapy 9, 851-861, 2018
202018
Spiking Neurons: Is coincidence-factor enough for comparing responses with fluctuating membrane voltage?
M Sarangdhar, C Kambhampati
Proceedings of the world congress on engineering 2, 2-4, 2008
112008
Rheumatic and musculoskeletal adverse events with immune checkpoint inhibitors: data from the United States Food and Drug Administration adverse event reporting system
XN Pundole, M Sarangdhar, ME Suarez-Almazor
Journal of Immunotherapy and Precision Oncology 2 (3), 65-73, 2019
102019
Therapeutic Opportunities for Intestinal Angioectasia‐Targeting PPARγ and Oxidative Stress
M Sarangdhar, MB Yacyshyn, AR Gruenzel, MA Engevik, NL Harris, ...
Clinical and Translational Science 14 (2), 518-528, 2021
72021
System and method for data mining very large drugs and clinical effects databases
B Aronow, M Sarangdhar, SC Tabar, AG Jegga
US Patent 10,769,242, 2020
62020
Spiking Neurons and Synaptic Stimuli: Neural Response Comparison Using Coincidence-Factor
M Sarangdhar, C Kambhampati
Advances in Electrical Engineering and Computational Science, 681-692, 2009
62009
Spiking Neurons and Synaptic Stimuli: Determining the Fidelity of Coincidence-Factor in Neural Response Comparison.
M Sarangdhar, C Kambhampati
Engineering Letters 16 (4), 2008
62008
A numerical model for Hodgkin-Huxley neural stimulus reconstruction
M Sarangdhar, C Kambhampati
IAENG International Journal of Computer Science 38 (1), 89-94, 2011
52011
Tumor lysis syndrome associated with monoclonal antibodies in patients with multiple myeloma: a pharmacovigilance study based on the FAERS database
S Xia, H Gong, Y Zhao, L Guo, Y Wang, R Ma, B Zhang, M Sarangdhar, ...
Clinical Pharmacology & Therapeutics 114 (1), 211-219, 2023
42023
A systems approach points to a therapeutic role for retinoids in asparaginase-associated pancreatitis
CY Tsai, T Saito, M Sarangdhar, M Abu-El-Haija, L Wen, B Lee, M Yu, ...
Science translational medicine 15 (687), eabn2110, 2023
42023
Pneumocystis jirovecii pneumonia associated with immune checkpoint inhibitors: a systematic literature review of published case reports and disproportionality analysis based on …
S Xia, H Gong, Y Wang, L Liu, Y Zhao, B Zhang, M Sarangdhar, ...
Frontiers in pharmacology 14, 1129730, 2023
42023
Do antibody–drug conjugates increase the risk of sepsis in cancer patients? A pharmacovigilance study
S Xia, YC Zhao, L Guo, H Gong, YK Wang, R Ma, BK Zhang, Y Sheng, ...
Frontiers in Pharmacology 13, 967017, 2022
42022
Using systems biology-based analysis approaches to identify mechanistically significant adverse drug reactions: Pulmonary complications from combined use of anti-TNFα agents …
M Sarangdhar, A Kushwaha, J Dahlquist, A Jegga, B Aronow
AMIA Summits on Translational Science Proceedings 2013, 151, 2013
42013
Association of pulmonary sepsis and immune checkpoint inhibitors: A pharmacovigilance study
S Xia, H Gong, Y Zhao, L Guo, Y Wang, B Zhang, M Sarangdhar, ...
Cancers 15 (1), 240, 2022
32022
Vitamin A and association with asparaginase-associated pancreatitis in children with acute lymphocytic leukemia.
CY Tsai, T Saito, M Sarangdhar, M Abu-El-Haija, L Wen, B Lee, ...
Journal of Clinical Oncology 40 (16_suppl), 10021-10021, 2022
22022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20